Atai Life Sciences (ATAI) Short Interest Ratio & Short Volume → This Could be Your “Big Money” AI Moment (From InvestorPlace) (Ad) Free ATAI Stock Alerts $1.73 +0.02 (+1.17%) (As of 05:18 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Atai Life Sciences Short Interest DataCurrent Short Interest6,310,000 sharesPrevious Short Interest5,900,000 sharesChange Vs. Previous Month+6.95%Dollar Volume Sold Short$12.49 millionShort Interest Ratio4.0 Days to CoverLast Record DateApril 30, 2024Outstanding Shares167,410,000 sharesFloat Size116,120,000 sharesShort Percent of Float5.43%Today's Trading Volume949,482 sharesAverage Trading Volume1,571,853 sharesToday's Volume Vs. Average60% Short Selling Atai Life Sciences ? Sign up to receive the latest short interest report for Atai Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATAI Short Interest Over TimeATAI Days to Cover Over TimeATAI Percentage of Float Shorted Over Time Ad Resource Stock DigestDigitizing the $11T commodities sector with one tiny stockOne tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long Atai Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20246,310,000 shares $12.49 million +7.0%5.4%4 $1.98 4/15/20245,900,000 shares $12.21 million +6.3%5.1%3.7 $2.07 3/31/20245,550,000 shares $10.93 million +6.5%4.8%3.2 $1.97 3/15/20245,210,000 shares $9.22 million +47.6%4.5%3.5 $1.77 2/29/20243,530,000 shares $6.85 million -27.5%3.0%2.5 $1.94 2/15/20244,870,000 shares $8.77 million +2.5%4.2%3.7 $1.80 Get the Latest News and Ratings for ATAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atai Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,750,000 shares $8.46 million +7.7%4.2%3.8 $1.78 1/15/20244,410,000 shares $8.64 million +1.9%3.9%3.9 $1.96 12/31/20234,330,000 shares $6.11 million -4.2%3.8%4.3 $1.41 12/15/20234,520,000 shares $5.70 million -6.6%4.0%6.1 $1.26 11/30/20234,840,000 shares $5.03 million -4.9%4.2%7.8 $1.04 11/15/20235,090,000 shares $6.11 million -9.6%4.5%9.7 $1.20 10/31/20235,630,000 shares $6.92 million +20.6%4.9%11.1 $1.23 10/15/20234,670,000 shares $5.98 million -0.6%4.1%8.7 $1.28 9/30/20234,700,000 shares $6.06 million +3.3%4.1%6.4 $1.29 9/15/20234,550,000 shares $6.60 million +10.4%4.0%5.3 $1.45 8/31/20234,120,000 shares $6.30 million -0.2%3.6%4.3 $1.53 8/15/20234,130,000 shares $6.65 million +1.0%3.6%4.2 $1.61 7/31/20234,090,000 shares $8.55 million +0.3%3.6%4.1 $2.09 7/15/20234,080,000 shares $8.24 million -9.7%3.5%3.9 $2.02 6/30/20234,520,000 shares $7.77 million -6.4%3.9%4.2 $1.72 6/15/20234,830,000 shares $8.65 million -2.8%4.2%4.3 $1.79 5/31/20234,970,000 shares $8.90 million -2.9%4.3%4.6 $1.79 5/15/20235,120,000 shares $10.24 million -3.4%4.4%4.5 $2.00 4/30/20235,300,000 shares $10.12 million +6.2%4.6%4.4 $1.91 4/15/20234,990,000 shares $9.38 million +3.1%4.3%3.8 $1.88 3/31/20234,840,000 shares $8.76 million +14.4%4.1%3.4 $1.81 3/15/20234,230,000 shares $5.20 million +3.9%3.5%3.1 $1.23 2/28/20234,070,000 shares $6.84 million +5.2%3.3%3 $1.68 2/15/20233,870,000 shares $6.97 million -14.0%3.2%2.8 $1.80 1/31/20234,500,000 shares $8.01 million -24.6%3.7%3 $1.78 1/15/20235,970,000 shares $10.75 million +1.5%4.9%4.3 $1.80 12/30/20225,880,000 shares $15.64 million +7.5%4.8%4.8 $2.66 12/15/20225,470,000 shares $16.74 million +9.2%4.5%5.7 $3.06 11/30/20225,010,000 shares $17.69 million +5.5%4.1%5.7 $3.53 11/15/20224,750,000 shares $13.68 million -13.2%3.9%5.6 $2.88 10/31/20225,470,000 shares $16.14 million -12.9%4.5%7.8 $2.95 10/15/20226,280,000 shares $18.90 million -2.0%5.2%8.8 $3.01 9/30/20226,410,000 shares $21.22 million -1.1%5.3%8.6 $3.31 9/15/20226,480,000 shares $26.83 million +0.9%5.5%8.4 $4.14Read this before you buy AI stocks (Ad)BREAKING: New "Formula" Could Lead to Huge AI Payouts When you click here and see what Elon Musk's new invention does… Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. 8/31/20226,420,000 shares $28.89 million +3.6%5.5%8.1 $4.50 8/15/20226,200,000 shares $29.02 million +9.7%5.3%7.5 $4.68 7/31/20225,650,000 shares $21.81 million +9.9%4.8%6.5 $3.86 7/15/20225,140,000 shares $21.85 million -13.5%4.4%6.1 $4.25 6/30/20225,940,000 shares $21.62 million +35.6%5.1%7.3 $3.64 6/15/20224,380,000 shares $14.50 million +9.0%3.8%5.1 $3.31 5/31/20224,020,000 shares $16.00 million +1.8%3.4%4.6 $3.98 5/15/20223,950,000 shares $14.38 million +21.5%3.4%4.7 $3.64 4/30/20223,250,000 shares $13.94 million +10.9%2.8%3.8 $4.29 4/15/20222,930,000 shares $15.59 million +4.3%2.5%3.4 $5.32 3/31/20222,810,000 shares $14.30 million -11.9%2.4%2.9 $5.09 3/15/20223,190,000 shares $15.76 million +8.1%2.7%3.3 $4.94 2/28/20222,950,000 shares $16.93 million -9.0%2.5%2.6 $5.74 2/15/20223,240,000 shares $19.12 million -17.8%2.7%2.9 $5.90 1/31/20223,940,000 shares $21.00 million +14.5%3.3%3.7 $5.33 1/15/20223,440,000 shares $20.50 million -19.4%2.9%3.4 $5.96 12/31/20214,270,000 shares $32.58 million +50.9%3.7%4.8 $7.63 12/15/20212,830,000 shares $19.30 million +25.2%2.4%3.7 $6.82 11/30/20212,260,000 shares $24.81 million +11.3%2.0%5 $10.98 11/15/20212,030,000 shares $26.09 million -1.0%1.8%4.9 $12.85 10/29/20212,050,000 shares $29.91 million +0.5%1.9%5.8 $14.59 10/15/20212,040,000 shares $27.54 million +2.0%1.9%6.7 $13.50 9/30/20212,000,000 shares $29.58 million +16.3%1.8%6.3 $14.79 9/15/20211,720,000 shares $26.13 million +10.3%1.6%5 $15.19 8/31/20211,560,000 shares $25.55 million +14.7%1.4%2.9 $16.38 8/13/20211,360,000 shares $18.52 million No Change1.2%2.2 $13.62 ATAI Short Interest - Frequently Asked Questions What is Atai Life Sciences' current short interest? Short interest is the volume of Atai Life Sciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 6,310,000 shares of ATAI short. 5.43% of Atai Life Sciences' shares are currently sold short. Learn More on Atai Life Sciences' current short interest. What is a good short interest ratio for Atai Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATAI shares currently have a short interest ratio of 4.0. Learn More on Atai Life Sciences's short interest ratio. Which institutional investors are shorting Atai Life Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Atai Life Sciences: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Atai Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.43% of Atai Life Sciences' floating shares are currently sold short. Is Atai Life Sciences' short interest increasing or decreasing? Atai Life Sciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 6,310,000 shares, an increase of 6.9% from the previous total of 5,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Atai Life Sciences' float size? Atai Life Sciences currently has issued a total of 167,410,000 shares. Some of Atai Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Atai Life Sciences currently has a public float of 116,120,000 shares. How does Atai Life Sciences' short interest compare to its competitors? 5.43% of Atai Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Atai Life Sciences: Mersana Therapeutics, Inc. (8.92%), Erasca, Inc. (10.23%), Nektar Therapeutics (1.99%), Nkarta, Inc. (14.02%), Kamada Ltd. (0.12%), ADC Therapeutics SA (1.43%), Verastem, Inc. (3.49%), Atea Pharmaceuticals, Inc. (2.43%), UroGen Pharma Ltd. (18.89%), Vanda Pharmaceuticals Inc. (4.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Atai Life Sciences stock? Short selling ATAI is an investing strategy that aims to generate trading profit from Atai Life Sciences as its price is falling. ATAI shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Atai Life Sciences? A short squeeze for Atai Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATAI, which in turn drives the price of the stock up even further. How often is Atai Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATAI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Mersana Therapeutics Short Interest Data Erasca Short Interest Data Nektar Therapeutics Short Interest Data Nkarta Short Interest Data Kamada Short Interest Data ADC Therapeutics Short Interest Data Verastem Short Interest Data Atea Pharmaceuticals Short Interest Data UroGen Pharma Short Interest Data Vanda Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATAI) was last updated on 5/20/2024 by MarketBeat.com Staff From Our Partners"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestElon to Transform U.S. Economy? Porter & Company